Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-Label, Rollover Study for Participants with Thyroid Eye Disease Previously Enrolled in Amg... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805434) titled 'AI-Based Personalized Digital Management for High-Risk Pulmonary Nodule Follow-up' on Sept.... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Struct... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Randomized, Crossover Study to Investigate the Relative Bioavailability of ... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Solid tumor Study for Long term Treatment of Cancer Patients Who Have Participated in BMS-Parent S... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicentre, Phase II Platform Study of Datopotamab Deruxtecan (Dato-DXd)-based Combinat... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase Ib, Open-Label, Multicenter Study of EBC-129 Combined With Osimertinib in Patients With Ad... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805109) titled 'Subclinical Renal Dysfunction in Rheumatoid Arthritis' on Sept. 01. Brief Summary: This co... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More